Narisa Tantai
Biographic Data
| ID | 9996076 |
|---|---|
| NAME | Narisa Tantai |
| GIVEN NAMES | Narisa |
| FAMILY NAME | Tantai |
| SIGNATURE | TANTAI N |
| AFFILIATIONS | Siriraj Hospital |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
A cost-utility analysis of BRCA1 and BRCA2 testing in high-risk breast cancer patients and family members in Thailand
Background: variants (gBRCA) in high-risk breast cancer patients is known to be cost-effective in high-income countries. Nationwide adoption of genetics testing in high-risk breast cancer population remains poor. Our study aimed to assess gBRCA health economics data in the middle-income country setting of Thailand. Methods: Decision tree and Markov model were utilized to assess cost-utility between the testing vs. no-testing groups from a societa…
No prominent works on this page.
A cost-utility analysis of BRCA1 and BRCA2 testing in high-risk breast cancer patients and family members in Thailand
Background: variants (gBRCA) in high-risk breast cancer patients is known to be cost-effective in high-income countries. Nationwide adoption of genetics testing in high-risk breast cancer population remains poor. Our study aimed to assess gBRCA health economics data in the middle-income country setting of Thailand. Methods: Decision tree and Markov model were utilized to assess cost-utility between the testing vs. no-testing groups from a societa…
BRCA gene mutations in cancer (1 work) · Breast cancer (1 work) · Cancer (1 work) · Cost effectiveness (1 work) · Environmental health (1 work) · Genetic testing (1 work) · Genomics and Rare Diseases (1 work) · Health Systems, Economic Evaluations, Quality of Life (1 work) · Internal Medicine (1 work) · Medicine (1 work)